|
|
Article: Bio-Technology General receives human superoxide dismutase patent.
- Article from:
- PR Newswire
- Article date:
- May 3, 1988
CopyrightCOPYRIGHT 1988 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BIO-TECHNOLOGY GENERAL RECEIVES HUMAN SUPEROXIDE DISMUTASE PATENT
NEW YORK, May 3 /PRNewswire/ -- Bio-Technology General Corp. (NASDAQ: BTGC) announced that the United States Patent and Trademark Office has today issued a U.S. Letters Patent No. 4,742,004, on a method for producing enzymatically active human copper/zinc superoxide dismutase (hSOD), a substance believed capable of substantially reducing the tissue damage occurring after a heart attack or other trauma.
The patent, the first to be issued for genetically engineered human SOD, broadly covers the production of human copper/zinc superoxide dismutase in bacteria and will block competitors ...